Home Mf Research Tata India Pharma Healthcare Fund Regular Plan Growth

Tata India Pharma & Healthcare Fund Regular Plan Growth

-
-
  • 1W
  • 2W
  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • 10Y
  • SI
Fund info
NAV (as on 2026-08-31)
₹33.88 0.28%
AUM (Fund Size)
1455.16 Cr
Expense Ratio
N/A
Exit load
Exit load of 2,500.00% if redeemed within 30 days.
Risk
Very High
AMC
Tata Mutual Fund
View AMC Details

SIP Returns

Period Invested for ₹1000 SIP Started on Investments Latest Value Abs. Returns
One Week 2026-08-24 ₹1,000.00 ₹1,008.01
0.80 %
Two Week 2026-08-17 ₹1,000.00 ₹1,010.23
1.02 %
One Month 2026-08-03 ₹1,000.00 ₹997.28
-0.27 %
Three Months 2026-06-02 ₹3,000.00 ₹3,140.73
4.69 %
Six Months 2026-03-04 ₹6,000.00 ₹6,599.36
9.99 %
One Year 2025-09-01 ₹12,000.00 ₹13,397.67
11.65 %
Three Year 2023-09-01 ₹36,000.00 ₹44,378.27
23.27 %
Five Year 2021-09-01 ₹60,000.00 ₹93,021.40
55.04 %
Ten Year 2016-09-02 ₹120,000.00 ₹302,025.19
151.69 %
Since Inception 2015-12-28 ₹130,000.00 ₹333,101.57
156.23 %

Return Calculator

SIP Amount
1M
6M
1Y
3Y
5Y
Investment
₹0
Maturity Value
₹0
Abs. Returns
0
Current CAGR
0

Portfolio

Allocation of Equity and Debt Asset Classes.

Equity N/A
Debt N/A
Others N/A

Sectors Holding in Tata India Pharma & Healthcare Fund Regular Plan Growth

Pharmaceuticals & Biotechnology
59.7%
Healthcare Services
32.32%
Fertilizers & Agrochemicals
4.17%
Other
2.58%
Personal Products
1.23%

Companies Holding in Tata India Pharma & Healthcare Fund Regular Plan Growth

SUN PHARMACEUTICAL INDUSTRIES LTD
8.51%
MAX HEALTHCARE INSTITUTE LTD
5.68%
HEALTHCARE GLOBAL ENTERPRISES LTD
5.52%
DIVI LABORATORIES LTD
5.12%
ABBOTT INDIA LTD
4.97%
CIPLA LTD
4.77%
APOLLO HOSPITALS ENTERPRISE LTD
4.61%
RAINBOW CHILDRENS MEDICARE LTD
4.42%
DR REDDYS LABORATORIES LTD
4.26%
GLAXOSMITHKLINE PHARMACEUTICALS LTD
4.12%
MANKIND PHARMA LTD
3.85%
FORTIS HEALTHCARE LTD
3.35%
BAYER CROPSCIENCE LTD
3.2%
LUPIN LTD
2.81%
SYNGENE INTERNATIONAL LTD
2.73%
ALKEM LABORATORIES LTD
2.64%
SAI LIFE SCIENCES LTD
2.53%
PFIZER LTD
2.5%
FDC LTD
2.34%
GLOBAL HEALTH LTD
2.32%
PROCTER & GAMBLE HEALTH LTD
1.79%
CONCORD BIOTECH LTD
1.76%
DR. LAL PATH LABS LTD
1.64%
NEULAND LABORATORIES LTD
1.6%
AJANTA PHARMA LTD
1.6%
SANOFI INDIA LTD
1.53%
METROPOLIS HEALTHCARE LTD
1.45%
GILLETTE INDIA LTD
1.23%
TORRENT PHARMACEUTICALS LTD
1.02%
SUMITOMO CHEMICAL INDIA LTD
0.97%
JUBILANT PHARMOVA LTD
0.91%
DR. AGARWALS HEALTH CARE LTD
0.6%
IPCA LABORATORIES LTD
0.58%
ZIM LABORATORIES LTD
0.49%
F) REPO
0.24%
CASH / NET CURRENT ASSET
2.34%

Risk Ratios

Std. Deviation 16.74%
Beta 0.91
Sharpe Ratio 0.90
Lock In Period N/A
Residual Maturity N/A

Standard Deviation:

Standard deviation numbers measure the variability or volatility of a fund's returns over a specific time period (often 3 years).
  • Low standard deviation = Stable, predictable returns → Suitable for conservative investors seeking stability.
  • High standard deviation = High volatility, more risk → Be cautious, suitable for risk-tolerant investors who can handle fluctuations.

Beta:

Beta measures a fund's volatility about the market or a benchmark. A lower beta means the fund's performance is less sensitive to market movements, making it more predictable compared to the market.
  • Low beta = Less sensitive to market changes → Great for investors with less market exposure.
  • High beta = More sensitive to market changes → Better for aggressive investors who seek higher returns but can handle market risks.

Sharpe Ratio:

The Sharpe Ratio measures how much return a fund has made compared to the risk it carries. A higher Sharpe ratio indicates better returns relative to the risk taken, meaning the fund delivers more efficiently.
  • A higher Sharpe ratio indicates better risk-adjusted returns → Look for funds with higher ratios for better return efficiency.
  • Use it to compare different funds' efficiency in generating returns relative to the risk taken.

Lock-In Period:

India's "lock-in period" in mutual funds encourages long-term investment, particularly in tax-saving schemes preventing redemption or selling of units.

Lock-in times for various investment types

  • Most ELSS mutual fund holders hold for 3 years.
  • Tax savings FDs lock in for 5 years.
  • The lock-in period for 8% Government of India bond investment is 6 years.
  • ULIPs must be locked in for 5 years.
  • The average hedge fund holding period is 30-90 days.
  • The average PPF investor holds onto their money for 15 years.

Residual Maturity:

Residual maturity is the remaining time until a security reaches its maturity date. It is an important factor for investors to consider when evaluating the risk associated with an investment.

There are two different types of residual maturity.

  • Short-term residual maturity: This occurs when a security has less than a year left on its maturity.
  • Long-term residual maturity: This occurs when a security has more than a year left on its remaining maturity.

Risk-O-Meter

Investors understand that their principal will be at
Very High

Scheme Objective

The investment objective of the scheme is to seek long term capital appreciation by investing atleast 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved.The Scheme does not assure or guarantee any returns.

Scheme Details

Min. SIP Amount
N/A
Min. Lumpsum Amount
N/A
AUM (in Cr.)
N/A
Expense Ratio Regular
N/A
Expense Ratio Direct
N/A
Lock-in Period
N/A
Fund Age
N/A
Benchmark
BSE HC
Fund managers
Rajat Srivastava
10 Years Experience

Exit Load

Exit load of 2,500.00% if redeemed within 30 days .

FAQs

Is a Mutual Fund with a Lower NAV Better?

What Are the Charges in Mutual Fund Investments?

What Are the Tax Benefits of Mutual Funds?

Is It a Good Time to Invest in Mutual Funds?

What Is the Difference Between Dividend and Growth Plans?

Should I Invest in Infrastructure Funds?

What Are Sector-Specific Funds/Schemes?

What Happens If I Miss an SIP Payment?

How Can I Compare Different Mutual Funds?